Iron transport via ferroportin is also thought to be impaired in the Parkinson’s disease SNc, since the combined reduction in β-amyloid precursor protein and soluble tau destabilizes the structure of ferroportin at the cell surface40–42. Here, SLC40A1 is linked to Parkinson disease.